Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1 Classical hematology 1 CNS 1

Conditions

Neuroblastoma 1

Interventions

Radiotherapy 63 Temozolomide 59 Magnetic Resonance Spectroscopy 46 Carboplatin 40 Cyclophosphamide 39 Vincristine 35 Specimen Handling 28 Etoposide 26 Cisplatin 26 Radiation 22 Chemotherapy, Adjuvant 22 Filgrastim 20 Bevacizumab 20 Doxorubicin 18 Peripheral Blood Stem Cell Transplantation 17 Biopsy 17 Vorinostat 16 Surgical Procedures, Operative 14 Melphalan 13 Immunoglobulin G 13 Disulfides 13 Radiotherapy, Conformal 12 Isotretinoin 12 Erlotinib Hydrochloride 12 X-Rays 11 Nivolumab 11 Irinotecan 11 Carmustine 11 aldesleukin 10 Topotecan 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × XK 469 × CNS × Clear all

NCT00028522 2013-12-16

R(+)XK469 in Treating Patients With Advanced Neuroblastoma

National Cancer Institute (NCI)

Phase 1 Completed

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡